Tuesday, 26 September 2023



LATEST NEWS Director JKEDI Ajaz Ahmad Bhat reviews progress of developmental initiatives at Shadab Karewa Shopian DC Ganderbal Shyambir kick-starts plantation drive under Swachhta Hi Sewa campaign DLRC/ DCC meeting held at Shopian DC Bandipora Dr. Owais Ahmad chairs meeting to finalize arrangements for Eid Milad-un-Nabi (SAW) at Bandipora Lt Governor releases Mukesh Singh & Anupama Pandey’s book “Curse of the Pir” Vigilance registers case against former Finance Minister Manpreet Singh Badal, Arrests three accused Chief Minister Sukhvinder Singh Sukhu launches website & promo of Pre-World Cup Paragliding event Wamiqa Gabbi takes inspiration from Phoebe Waller Bridge for her role in Charlie Chopra and the Mystery of Solang Valley Fingerprint Publishing releases Farooq of Kashmir, a powerful political biography of Dr Farooq Abdullah Punjab government to address mushroom growers' issues promptly for ensuring crop diversification, assures Chetan Singh Jauramajra Supreme Audit Institution hosts ClimateScanner Event in Abu Dhabi "Mann Jogiya : A Musical Journey through Rishikesh's Serenity" The Centre for cGMP at MAHE, Manipal, is gearing up for the inaugural "NATIONAL cGMP DAY" set to take place on October 10th Bollywood Newcomer Janmejaya Singh Set to Steal Hearts in 'Hum Tumhein Chahte Hai' on October 13th The UAE Council for Fatwa organizes press conference to announce details of its Second International Conference Narendra Modi flags off nine Vande Bharat Express trains Home Minister Anil Vij warmly welcomed BJP state in-charge Biplab Deb at his residence in Ambala Sukhvinder Singh Sukhu inaugurates the curtain raiser and releases brochure for International Kullu Dussehra Festival Students of Loreto Convent Tara Hall donates towards Aapda Rahat Kosh Revenue Minister Jagat Singh Negi calls on Governor Shiv Pratap Shukla 800 Dwarka Residents and Doctors from HCMCT Manipal Hospitals Walk Together to Raise Awareness on Heart Health


Common diabetes drug may cut long Covid risk by 40%: Lancet

Omicron Variant, Delta Plus Covid variant, Delta Covid-19 variant, Coronavirus, Health, Research, Study, Researchers, COVID 19, Novel Coronavirus, Fight Against Corona, Covaxin, Covishield, Oxygen, SARS-CoV-2, Sputnik V, Oxygen Plants, Pfizer, Astra Zeneca, Oxygen Concentrator, Remdesivir, Liquid Medical Oxygen, Oximeter
Listen to this article

Web Admin

Web Admin

5 Dariya News

New York , 09 Jun 2023

Taking a two-week course of metformin, a safe and affordable diabetes medication, after testing positive for SARS-CoV-2, may lead to 40 per cent fewer long Covid risk, according to a results of trial published in The Lancet Infectious Diseases journal.

Currently, there are no proven treatments or ways to prevent long Covid, other than reducing the risk of infection in the first place.The phase 3 trial is the first to show a medication that can reduce the risk of long Covid when taken after testing positive for SARS-CoV-2, said researchers from University of Minnesota, US.

However, the results do not indicate whether metformin would be effective as a treatment for those who already have long Covid, they said."Long Covid is a significant public health emergency that may have lasting physical health, mental health, and economic impacts, especially in socioeconomically marginalised groups. 

There is an urgent need to find potential treatments and ways to prevent this disease," said first author Dr Carolyn Bramante from the varsity's Medical School."Previous studies have found that metformin stops the SARS-CoV-2 virus from replicating in the lab, which is consistent with predictions from our mathematical modelling of viral replication, so that might be what is causing the reduction in both severe Covid-19 and long Covid diagnoses seen in this trial," said co-author David Odde, a biomedical engineer at University of Minnesota.

The study included 1,126 patients who were given either metformin or an identical placebo pill after testing positive for SARS-CoV-2 between December 2020 to January 2022. Participants were followed up for 10 months with data gathered by self-report questionnaire every 30 days.

In the trial, 6.3 per cent (35/564) of participants given metformin reported a long Covid diagnosis within 10 months of follow up, compared to 10.4 per cent (58/562) of those receiving an identical placebo.

These findings reflect previously published results from this trial which found metformin prevented over 40 per cent of emergency department visits, hospitalisations, and deaths due to Covid within two weeks of starting the treatment, compared to a placebo.

Other arms of the trial looked at ivermectin and fluvoxamine and found that neither prevented long Covid.The researchers also acknowledge some limitations to the study, including that the trial excluded those with a BMI under 25 and those younger than 30 years, and therefore it is unknown if these findings could be generalised to those populations.

"If confirmed, the findings are profound and potentially landmark (a) this is the first high-quality evidence from a randomised controlled trial to show that the incidence of long Covid can be reduced by a medical intervention, metformin -- an inexpensive treatment with which clinicians have ample experience," said Dr Jeremy Faust of Harvard Medical School, who was not involved in this research.


Tags: Omicron Variant , Delta Plus Covid variant , Delta Covid-19 variant , Coronavirus , Health , Research , Study , Researchers , COVID 19 , Novel Coronavirus , Fight Against Corona , Covaxin , Covishield , Oxygen , SARS-CoV-2 , Sputnik V , Oxygen Plants , Pfizer , Astra Zeneca , Oxygen Concentrator , Remdesivir , Liquid Medical Oxygen , Oximeter



related news




Photo Gallery



Video Gallery



5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2023 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD